LYCA

Lycia Therapeutics, Inc. (LYCA)

Healthcare • NASDAQ • $28.61-8.30%

Key Fundamentals
Symbol
LYCA
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$28.61
Daily Change
-8.30%
Market Cap
$1.63B
Trailing P/E
N/A
Forward P/E
N/A
52W High
$36.49
52W Low
$22.19
Analyst Target
N/A
Dividend Yield
0.00%
Beta
N/A
About Lycia Therapeutics, Inc.

Lycia Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics designed to degrade disease-causing extracellular proteins for the treatment of autoimmune, inflammatory, and allergic diseases. The company develops the LYTAC platform, a modular technology designed to create therapeutics that selectively reduce the levels of pathogenic proteins. Its therapeutic candidate LCA-0061 degrades immunoglobulin E (IgE) for the treatment of allergic diseases, including food allergy. The company also develops LCA-0062, a follow-on program designed to degrade IgE for the treatment of allergic diseases. Additionally, it develops LCA-0321, a candidate designed to selectively degrade TSHR autoantibodies (thyrotropin receptor antibodies, or TRAbs), the pathogenic…

Company website

Research LYCA on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...